[Immune-mediated pathogenesis and management of pediatric aplastic anemia]. 2006

Yong-lan Huang, and Shao-liang Huang

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000741 Anemia, Aplastic A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. Anemia, Hypoplastic,Aplastic Anaemia,Aplastic Anemia,Anaemia, Aplastic,Aplastic Anaemias,Aplastic Anemias,Hypoplastic Anemia,Hypoplastic Anemias
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Yong-lan Huang, and Shao-liang Huang
January 2005, Hematology. American Society of Hematology. Education Program,
Yong-lan Huang, and Shao-liang Huang
January 1990, The American journal of pediatric hematology/oncology,
Yong-lan Huang, and Shao-liang Huang
June 1988, Asian Pacific journal of allergy and immunology,
Yong-lan Huang, and Shao-liang Huang
June 1985, The Tokai journal of experimental and clinical medicine,
Yong-lan Huang, and Shao-liang Huang
December 1974, Haematologica,
Yong-lan Huang, and Shao-liang Huang
May 1978, Nihon rinsho. Japanese journal of clinical medicine,
Yong-lan Huang, and Shao-liang Huang
December 2019, Hematology (Amsterdam, Netherlands),
Yong-lan Huang, and Shao-liang Huang
September 2009, Autoimmunity reviews,
Yong-lan Huang, and Shao-liang Huang
May 2014, Genetics and molecular research : GMR,
Yong-lan Huang, and Shao-liang Huang
January 2007, Hematology. American Society of Hematology. Education Program,
Copied contents to your clipboard!